cancerregulome.org Report : Visit Site

Technical data of the cancerregulome.org

Geo IP provides you such as latitude, longitude and ISP (Internet Service Provider) etc. informations. Our GeoIP service found where is host cancerregulome.org. Currently, hosted in United States and its service provider is vanoppen.biz LLC .

HTTP Header Analysis

HTTP Header information is a part of HTTP protocol that a user's browser sends to called nginx containing the details of what the browser wants and will accept back from the web server.

DNS

HtmlToText

tcga genome data analysis center (gdac) for systems analysis of the institute for systems biology and md anderson cancer center the cancer genome atlas (tcga) provides an unprecedented opportunity to take an integrated approach toward a systems level understanding of regulatory disruptions in cancer. such disruptions and their consequences are intertwined within complex dynamical networks through a multitude of interactions among different types of molecules. understanding such relationships requires multivariate analysis methods that can be effective in the context of highly heterogeneous data, measurement uncertainty, and missing data. "comprehensive molecular characterization of gastric adenocarcinoma" regulome explorer : explore, mine, and visualize complex datasets the cover of cancer cell features: "integrated analyses identify a master microrna regulatory network for the mesenchymal subtype in serous ovarian cancer" crc aggressiveness : explore features related to colorectal cancer aggressiveness ‹ › research development of novel computational approaches for analyzing large-scale heterogeneous data. view details » cancer studies our participation and contribution to multiple tcga tumor analysis working groups. view details » software web-based interactive visualization and exploratory tools that promote collaborative research. view details » news & events ← newer older → may 2016 the tcga research network published a study on adrenocortical carcinoma (acc) in cancer cell . the study describes the comprehensive analysis of 91 acc specimens from four continents using state of the art genomic technologies and computational methods. in addition to identification of novel acc driver genes, pathways and refined subtypes, the awg analysis revealed whole genome doubling (wgd) as a milestone in disease progression. we performed integrated analysis across different data types for this study and captured statistical associations in regulome explorer . november 2015 the tcga research network published a study on primary prostate cancer in cell . the study described a molecular taxonomy in which 74% of the tumors belonged to one of seven subtypes. this study revealed additional molecular heterogeneity among primary prostate cancers and molecular defects which may be therapeutically actionable. we performed integrated analysis across different data types for this study. associations for the 333 tumor dataset can be viewed in regulome explorer . june 2015 the tcga research network published a study on diffuse lower-grade gliomas (lgg) in the new england journal of medicine . the study concluded that there were three molecular classes of lgg. the majority of lggs without an idh mutation exhibited similar molecular and clinical properties to glioblastoma. associations for the lgg dataset can be viewed in regulome explorer . we also participated in the tcga study of cutaneous melanoma published in cell . the multidimensional study looked at 331 patients and identified immune signatures associated with improved survival. october 2014 the tcga research network published a study on papillary thyroid cancer (ptc) in cell . the study concluded that the subgroups of ptc differ in their molecular alterations as well as signaling and differentiation characteristics. the paper proposes a refined classification of ptc to reflect these differences and to better inform clinical management of the disease. we made significant contributions to this study by performing integrated analysis across different data types. associations for the full tumor dataset and the brafv600e tumor dataset can be viewed in regulome explorer . july 2014 the tcga research network published a study on gastric cancer in nature with substantial contributions from members of our center. dr. shmulevich served as one of the co-chairs of the study group. one of the main results of the paper is that gastric tumors tend to fall into one of four subtypes . the treatment of gastric cancer may improve with therapy targeted against specific subtypes. associations within the dataset of 295 tumors can be viewed in regulome explorer . october 2013 a position paper is published in nature genetics describing the pan-cancer initiative, which compares the first 12 tumor types profiled by the cancer genome atlas (tcga) project. the data provide a major opportunity to develop an integrated picture of commonalities, differences and emergent themes across tumor lineages. nature also created a focused resource with threads and links to 18 pan-cancer papers. a related article also appeared in the los angeles times . we took part in the tcga study of glioblastoma, published in cell . the project released a new catalog of genetic-mutation data for nearly 600 glioblastoma cases. we also developed a companion open-access software tool (micro) that allows researchers to study the correlations between micrornas and proteins in detail. september 2013 we have been awarded a grant from washington state's life sciences discovery fund to develop web-based tools for analyzing cancer genetic data to advance understanding of tumor biology, accelerate new discoveries, and in the long term, facilitate personalized therapy. here is the press release from lsdf. there was also an article on genomeweb about this award. may 2013 new paper published in nature on "integrated genomic characterization of endometrial carcinoma" as part of the tcga network . april 2013 we were awarded the first prize in the yarcdata graph analytics challenge . the topic of our entry was drug repurposing for cancer and uses data from tcga , pubmed, and other databases. february 2013 investigators from our gdac have published the discovery and characterization of fgfr3-tacc3 fusion in 8% of glioblastoma in "the tumorigenic fgfr3-tacc3 gene fusion escapes mir-99a regulation in glioblastoma" . new paper published in cancer cell on "integrated analyses identify a master microrna regulatory network for the mesenchymal subtype in serous ovarian cancer" as part of the tcga network . the cover of cancer cell features the article, with a graphic depicting the analysis. november 2012 researchers at our center attended and presented at the 2nd annual tcga scientific symposium . the symposium was co-chaired by dr ilya shmulevich . dr brady bernard and hector rovira gave a talk on genespot : a portal for interactive gene-centric exploration of the cancer genome atlas. dick kreisberg presented a workshop on regulome explorer . october 2012 new paper published in nature on "comprehensive molecular portraits of human breast tumours" as a part of the tcga network . an article related to the work was published in the new york times . september 2012 the tcga project published a case study on "the new genomic bottleneck and how the cloud might widen it" in which dr ilya shmulevich is interviewed on his lab’s efforts to analyze genomic information using large computational clusters with cloud infrastructure on demand. july 2012 new paper published in nature on "comprehensive molecular characterization of human colon and rectal cancer" as part of the tcga network . an article related to the work was featured on the home page of the new york times . june 2012 our work was featured during the compute engine keynote presentation at the google i/o 2012 conference. the keynote, delivered by urs hölzle, senior vice president of infrastructure at google, introduced google compute engine. he demonstrated how rf-ace , a machine learning algorithm that learns associations among genomic and clinical features, can be scaled to 600,000 cores across google’s global data centers and the results visualized using a version of regulome explorer . a case study published by google discusses the integration with compute engine. may 2012 regulome explorer is featured in this article where isb founder dr. leroy hood talks about the application of mathematics to biological research. march 2012 regulome exp

URL analysis for cancerregulome.org

http://www.cancerregulome.org/#homecarousel
http://www.cancerregulome.org/cancerstudies.html
http://www.cancerregulome.org/software.html
http://www.cancerregulome.org/research.html

Whois Information

Whois is a protocol that is access to registering information. You can reach when the website was registered, when it will be expire, what is contact details of the site with the following informations. In a nutshell, it includes these informations;

Domain Name: CANCERREGULOME.ORG
Registry Domain ID: D157788296-LROR
Registrar WHOIS Server: whois.dreamhost.com
Registrar URL: http://www.dreamhost.com/
Updated Date: 2018-12-09T02:50:24Z
Creation Date: 2009-12-10T23:45:13Z
Registry Expiry Date: 2019-12-10T23:45:13Z
Registrar Registration Expiration Date:
Registrar: New Dream Network, LLC dba DreamHost Web Hosting
Registrar IANA ID: 431
Registrar Abuse Contact Email: [email protected]
Registrar Abuse Contact Phone: +213.2719359
Reseller:
Domain Status: ok https://icann.org/epp#ok
Registrant Organization: Proxy Protection LLC
Registrant State/Province: CA
Registrant Country: US
Name Server: NS1.DREAMHOST.COM
Name Server: NS2.DREAMHOST.COM
Name Server: NS3.DREAMHOST.COM
DNSSEC: unsigned
URL of the ICANN Whois Inaccuracy Complaint Form https://www.icann.org/wicf/)
>>> Last update of WHOIS database: 2019-08-11T20:42:46Z <<<

For more information on Whois status codes, please visit https://icann.org/epp

Access to Public Interest Registry WHOIS information is provided to assist persons in determining the contents of a domain name registration record in the Public Interest Registry registry database. The data in this record is provided by Public Interest Registry for informational purposes only, and Public Interest Registry does not guarantee its accuracy. This service is intended only for query-based access. You agree that you will use this data only for lawful purposes and that, under no circumstances will you use this data to (a) allow, enable, or otherwise support the transmission by e-mail, telephone, or facsimile of mass unsolicited, commercial advertising or solicitations to entities other than the data recipient's own existing customers; or (b) enable high volume, automated, electronic processes that send queries or data to the systems of Registry Operator, a Registrar, or Afilias except as reasonably necessary to register domain names or modify existing registrations. All rights reserved. Public Interest Registry reserves the right to modify these terms at any time. By submitting this query, you agree to abide by this policy.

The Registrar of Record identified in this output may have an RDDS service that can be queried for additional information on how to contact the Registrant, Admin, or Tech contact of the queried domain name.

  REFERRER http://www.pir.org/

  REGISTRAR Public Interest Registry

SERVERS

  SERVER org.whois-servers.net

  ARGS cancerregulome.org

  PORT 43

  TYPE domain

DOMAIN

  NAME cancerregulome.org

  HANDLE D157788296-LROR

  CREATED 2009-10-12

STATUS
ok https://icann.org/epp#ok

NSERVER

  NS1.DREAMHOST.COM 64.90.62.230

  NS2.DREAMHOST.COM 208.97.182.10

  NS3.DREAMHOST.COM 66.33.205.230

OWNER

  ORGANIZATION Proxy Protection LLC

ADDRESS

  STATE CA

  COUNTRY US

  REGISTERED yes

Mistakes

The following list shows you to spelling mistakes possible of the internet users for the website searched .